Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 592 of 6351
-
New trial aims to improve survival for a tough pancreatic cancer
Disease control Not yet recruitingPancreatic cancer is one of the most treatment resistant malignancies, often diagnosed at a late stage and associated with poor survival. The 5-year overall survival rate remains around 10%. Prognosis is affected by multiple factors including tumor stage, biology, treatment respo…
Phase 3 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:50 UTC
-
New study aims to pinpoint which Alzheimer's patients respond best to antibody drug
Disease control Not yet recruitingPreliminary clinical trial results indicate that Aβ-targeting monoclonal antibody drugs can delay disease progression more effectively. However, some patients still progress slowly to the moderate stage during treatment despite maintaining low Aβ/tau pathological protein loads. F…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
Internal radiation boost may help fight esophageal cancer when standard treatment fails
Disease control Recruiting nowThe goal of this clinical trial is to learn if adding high-dose-rate (HDR) brachytherapy can improve outcomes in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who have already received external beam radiotherapy (EBRT), chemotherapy, and the immune ther…
Phase 2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:32 UTC
-
New pill targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingTQB3201 is an orally administered targeted protein chimera (PROTAC) drug in which one end of the drug is attached to a ligand that binds to Androgen Receptor (AR) and the other end to a ligand of E3 ligase (CRBN) via a linker. The phase I phase of this trial aims to evaluate the …
Phase 1/2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:15 UTC
-
New study aims to prevent brain damage in preterm infants after bleeding
Disease control Not yet recruiting1. Establish a reference curve for the lateral ventricular diameter of premature infants and determine the intervention threshold for hydrocephalus after hemorrhage in premature infants based on the reference curve, providing a scientific basis for optimizing clinical interventio…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:25 UTC
-
AI body scans could make chemo safer for women with ovarian and endometrial cancer
Disease control Not yet recruitingThe dosage of paclitaxel, an adjuvant chemotherapy agent for endometrial and ovarian cancer, is typically calculated based on the patient's body surface area (BSA). However, cancer patients with the same BSA may exhibit significant differences in body composition, which could inf…
Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Engineered immune cells take on Hard-to-Treat melanoma
Disease control Stopped earlyThe purpose of this study is to assess the feasibility, safety and efficacy of multiple CAR-T cell therapy which targets NG2 and DLL3 surface antigens in patients with relapsed and refractory melanoma.
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter phase II study to evaluate the safety and efficacy of sac-TMT plus Tagitanlimab in patients with PD-L1-positive locally advanced or metastatic TNBC.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
Drug cocktail aims to shrink stomach tumors before surgery in small trial
Disease control Not yet recruitingEfficacy and safety of Iparomlimab and Tuvonralimab in combination with lenvatinib and SOX chemotherapy in potentially resectable MSI-H, dMMR locally advanced gastric or gastroesophageal junction adenocarcinoma patients: A prospective, multicenter, open-label Phase II single-arm …
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:09 UTC
-
Immunotherapy plus chemo shows promise for tough uterine cancer
Disease control Recruiting nowExploring the therapeutic effect of neoadjuvant chemotherapy combined with PD-1 inhibitor camrelizumab on advanced stage III-IV endometrial cancer
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Spinal stimulator trial aims to help paralyzed patients walk again
Disease control Recruiting nowSpinal cord stimulation (SCS) has been shown in previous studies to be capable of restoring motor and autonomic function in patients with chronic complete spinal cord injury (SCI). Clinical studies have demonstrated that SCS enables activation of previously paralyzed muscles, lea…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
RSV showdown: vaccine for moms vs. antibody for newborns – which works better?
Prevention OngoingBronchiolitis is a lower respiratory tract infection, extremely common in pediatrics, and potentially serious. Bronchiolitis affects nearly 30% of infants under 2 years old each year, representing approximately 480,000 cases annually worldwide. Each year, 2 to 3% of infants under…
Sponsor: Jean-Michel HASCOET • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
New hope for advanced liver cancer: experimental drug takes on standard therapy
Disease control OngoingThis is a Phase 2/3 study evaluating the efficacy and safety of Pracytarabine versus regorafenib in patients with advanced hepatocellular carcinoma (HCC) who have experienced treatment failure with standard systemic therapies involving targeted drugs and immune checkpoint inhibit…
Phase 2/3 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could less radiation be just as effective for neck cancer?
Disease control Recruiting nowBased on the pattern of nasopharyngeal carcinoma cervical lymph node metastasis, which typically follows a sequential downward spread with rare skip metastases and a tendency for ipsilateral neck involvement, and in accordance with the latest international guidelines, we propose …
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
PrEP goes local: Community-Based HIV prevention trial launches in rio
Prevention Recruiting nowThis study aims to improve access to HIV prevention using pre-exposure prophylaxis (PrEP) among underserved populations in Rio de Janeiro, including gay and bisexual men, transgender women, and sex workers. Despite the proven effectiveness of PrEP, many people at higher risk of H…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Robotic scalpel vs Surgeon's hand: which is safer for pancreatic cancer surgery?
Disease control Recruiting nowPancreatic surgery, specifically pancreatoduodenectomy (PD), is a complex procedure often required for patients with pancreatic or other periampullary cancers. In recent years, minimally invasive techniques have become more popular, especially robotic-assisted surgery. However, t…
Sponsor: Hospital del Mar • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can simulated sunlight reboot the brain after stroke?
Symptom relief CompletedGrounded in the exposome framework and the bio-psycho-social model of health, this study investigated the effects of artificial light simulating natural sunlight on autonomic regulation, cognitive-motor performance and brain activity in 30 chronic stroke survivors. The aim of the…
Sponsor: Dr. Franco Molteni • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a blue dye tame hepatitis b?
Disease control Recruiting nowHBV infection is a global public health problem. It is estimated that there are more than 250 million HBV carriers worldwide, of whom approximately 600,000 die each year from HBV-related liver disease. Diagnosis and treatment depend on the stage of infection, the degree of liver …
Phase 2 • Sponsor: Fondazione Epatocentro Ticino • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Blood test duo may flag sepsis in burn victims before symptoms worsen
Diagnosis CompletedThis study aimed to evaluate the value of procalcitonin and highly sensitive c-reactive protein as biomarkers for early detection of sepsis in patients with major burns.
Sponsor: Mansoura University • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Herbal extract may turn gym sessions into stress relief and brain boost
Disease control Recruiting nowThis clinical trial will study the effects of Ashwagandha (Withania somnifera), a natural plant extract, on physical and mental health in adult men. Ashwagandha is known for its potential to reduce stress, support hormonal balance and improve sleep and physical performance. The s…
Sponsor: Gdansk University of Physical Education and Sport • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC